Syra Health posts first profitable quarter in Q1 2026; net income $241K, EPS $0.02, revenue up 22%

Syra Health Corp

2026-Q1 EPS reported $0.02 revenue$2,273,520

Net income of $241,000 vs net loss of $(472,265) in Q1 2025; EPS $0.02 vs ($0.04).
Total revenue $2.3M (+22% YoY); population health solutions grew 46% to $1.8M.
Gross margin expanded to 42.7%, up 11 ppt from 31.7%.
Cash on hand $2.9M; no long-term debt as of March 31, 2026.
Adjusted EBITDA improved to $244,495 from $(462,239) in prior year.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Syra Health Corp reported first quarter ended March 31, 2026 results: revenue $2.3 million, net income $240,979, EPS $0.02 per share.

Period: first quarter ended March 31, 2026
Revenue: $2.3 million
Net income: $240,979
EPS: $0.02 per share
Result: reported results

Exact text from the filing

period ● Q1 2026 EPS grew to $0.02 per share versus ($0.04) in Q1 2025 ● Gross Margin rose to 42.7%, up 11 percentage points year-over-year ● Total revenue increased to $2.3 million, up 22% when compared to the prior year period Carmel, Ind., May 7, 2026 / PRNewswire – Syra Health Corp. (OTCQB: SYRA) (“Syra Health” or the “Company”), an integrated healthcare

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Syra Health Corp filing history →

Source: SEC EDGAR

accession 0001493152-26-021629

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.